Sharon R Lewin Selected Research

Coinfection

5/2020	Hepatitis C Virus (HCV) Clearance After Treatment With Direct-Acting Antivirals in Human Immunodeficiency Virus (HIV)-HCV Coinfection Modulates Systemic Immune Activation and HIV Transcription on Antiretroviral Therapy.
1/2020	Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection.
1/2020	Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?
1/2017	Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
1/2017	HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.
1/2016	Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity.
11/2015	Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients.
9/2014	Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy.
1/2014	Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy.
1/2014	CXCL-10, interleukin-12 and interleukin-21 are not immunological predictors of HBeAg seroconversion in HIV-1-HBV coinfection following HBV-active antiretroviral therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sharon R Lewin Research Topics

Disease

46	Infections 02/2022 - 03/2002
34	HIV Infections (HIV Infection) 02/2022 - 10/2002
24	Coinfection 05/2020 - 03/2005
11	Acquired Immunodeficiency Syndrome (AIDS) 10/2021 - 07/2005
10	Neoplasms (Cancer) 02/2022 - 01/2011
10	Latent Infection 01/2021 - 10/2011
8	Hepatitis 06/2021 - 07/2002
8	Cryptococcal Meningitis 01/2019 - 08/2013
7	Viremia 01/2022 - 05/2013
7	Chronic Hepatitis B 06/2021 - 07/2002
7	Liver Diseases (Liver Disease) 01/2017 - 07/2008
7	Inflammation (Inflammations) 01/2017 - 11/2007
7	Fibrosis (Cirrhosis) 01/2016 - 11/2007
6	Immune Reconstitution Inflammatory Syndrome 01/2019 - 07/2008
5	COVID-19 08/2022 - 01/2021
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 09/2008
5	Cryptococcosis 01/2019 - 08/2013
5	Hepatitis B 01/2013 - 07/2002
4	Disease Progression 01/2019 - 03/2005
3	Melanoma (Melanoma, Malignant) 01/2021 - 02/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2016 - 03/2011
2	Non-alcoholic Fatty Liver Disease 12/2019 - 01/2019
2	Virus Diseases (Viral Diseases) 01/2018 - 12/2017
1	Lethargy 01/2022
1	Type I Syndactyly 01/2022
1	Ataxia (Dyssynergia) 01/2022
1	Confusion (Bewilderment) 01/2022
1	Merkel Cell Carcinoma 01/2021

Drug/Important Bio-Agent (IBA)

17	RNA (Ribonucleic Acid)IBA 02/2022 - 02/2008
14	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2007
8	Hepatitis B e AntigensIBA 06/2021 - 09/2008
8	Tenofovir (Viread)FDA Link 01/2020 - 04/2009
7	Pharmaceutical PreparationsIBA 01/2022 - 02/2007
6	AntigensIBA 07/2021 - 07/2002
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2002
5	VaccinesIBA 07/2021 - 07/2002
5	Antiviral Agents (Antivirals)IBA 06/2021 - 02/2003
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2011
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 07/2002
5	LipopolysaccharidesIBA 10/2016 - 04/2011
5	ChemokinesIBA 01/2016 - 12/2007
5	Lamivudine (Epivir)FDA Link 01/2016 - 07/2002
4	enhanced green fluorescent proteinIBA 12/2019 - 06/2010
4	Alanine Transaminase (SGPT)IBA 01/2016 - 07/2008
4	Lipopolysaccharide ReceptorsIBA 09/2014 - 03/2011
3	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2018
3	NivolumabIBA 10/2021 - 01/2018
3	IpilimumabIBA 10/2021 - 02/2015
3	CytokinesIBA 06/2021 - 01/2011
3	InterferonsIBA 06/2021 - 01/2013
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2020
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 05/2013
3	Histone Deacetylase InhibitorsIBA 09/2020 - 01/2011
3	Interleukin-7 (Interleukin 7)IBA 10/2017 - 01/2011
3	Chemokine ReceptorsIBA 01/2016 - 11/2013
2	pembrolizumabIBA 01/2022 - 01/2018
2	Disulfiram (Antabuse)FDA Link 01/2022 - 12/2015
2	Nucleic AcidsIBA 07/2021 - 06/2010
2	LuciferasesIBA 01/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 09/2014
2	Vorinostat FDA Link 09/2020 - 07/2013
2	LigandsIBA 01/2019 - 12/2007
2	Emtricitabine (Emtriva)FDA Link 01/2016 - 01/2010
2	EnzymesIBA 09/2014 - 10/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2014 - 11/2007
2	Immunoglobulins (Immunoglobulin)IBA 01/2012 - 07/2002
2	AntibodiesIBA 07/2011 - 10/2009
2	prostratinIBA 04/2011 - 01/2011
2	RacivirIBA 01/2010 - 08/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2022
1	RNA Splice SitesIBA 01/2022
1	Neutralizing AntibodiesIBA 07/2021
1	B-Cell Activating FactorIBA 06/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Signal Recognition ParticleIBA 01/2021
1	avelumabIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	SolutionsIBA 01/2021
1	SofosbuvirIBA 05/2020
1	tat Gene Products (tat Protein)IBA 01/2020
1	Internal Ribosome Entry SitesIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	tesamorelin FDA Link 12/2019
1	Peptide Elongation Factor 1 (EF-1)IBA 12/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	InterleukinsIBA 01/2019
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2019
1	romidepsin (FK228)FDA Link 01/2019

Therapy/Procedure

42	Therapeutics 02/2022 - 03/2005
22	Highly Active Antiretroviral Therapy (HAART) 10/2017 - 02/2007
19	Art Therapy 03/2021 - 10/2009
3	Immunotherapy 01/2021 - 01/2016
3	Aftercare (After-Treatment) 05/2020 - 10/2002
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2016
2	Cesarean Section (Caesarean Section) 01/2012 - 08/2008
1	Stem Cell Transplantation 01/2022
1	Intravenous Administration 01/2022
1	Transplantation 01/2022